RetiPharma IVS — Credit Rating and Financial Key Figures

RetiPharma IVS (CVR number: 37134120) is a company from KØBENHAVN. The company recorded a gross profit of -147.1 kDKK in 2018. The operating profit was -158.4 kDKK, while net earnings were -203.9 kDKK. The profitability of the company measured by Return on Assets (ROA) was -3.9 %, which can be considered poor and Return on Equity (ROE) was -3.1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -2.8 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. RetiPharma IVS's liquidity measured by quick ratio was 11.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.